Navigation Links
Turning a cellular sentinel into a cancer killer

Howard Hughes Medical Institute researchers have developed two strategies to reactivate the p53 gene in mice, causing blood, bone and liver tumors to self destruct. The p53 protein is called the "guardian of the genome" because it triggers the suicide of cells with damaged DNA.

Inactivation of p53 can set the stage for the development of different types of cancer. The researchers' findings show for the first time that inactivating the p53 gene is necessary for maintaining tumors. While the researchers caution that cancers can mutate to circumvent p53 reactivation, they believe their findings offer ideas for new approaches to cancer therapy.

The research was carried out independently by two Howard Hughes Medical Institute (HHMI) research teams led by Tyler Jacks at the Massachusetts Institute of Technology and Scott Lowe at Cold Spring Harbor Laboratory. Both papers were published online January 24, 2007, in advance online publication articles in the journal Nature. Although researchers have long known that p53 inactivation plays a central role in the development of cancer, little was known about whether p53 inactivation played a role in maintaining cancers. And researchers were not sure whether switching p53 back on in tumor cells would have any therapeutic effect.

"It had been demonstrated that overexpressing p53 at very high levels could arrest or kill tumors, said Lowe. "But at such high levels, p53 might not be working through a physiological mechanism. So, it was an open question whether restoring the p53 pathway would have any anti-tumor effect." For one thing, the high mutation rate in cancers might enable a cancer to switch the p53 pathway back off, or to circumvent the pathway in some other fashion. For those reasons, researchers were not sure whether the pathway would be a useful therapeutic target.

To reactivate p53, Lowe and his colleagues used a genetic technique they had developed to induce an aggressive form of liver
'"/>

Source:Howard Hughes Medical Institute


Page: 1 2 3 4

Related biology news :

1. Turning viruses into allies against cancer
2. Turning green gunk to gold, anti-cancer gold
3. Scientists discover the cellular roots of graying hair
4. Vital step in cellular migration described by UCSD medical researchers
5. MSI releases moleculizer - a new approach to simulation of intracellular biochemical networks
6. New study to explore cellular circuitry
7. Study provides insight into cellular defenses against genetic mutation
8. Carnegie Mellon develops non-invasive technique to detect transplant rejection at cellular level
9. Liver cancer linked to cellular repair pathway
10. New cellular flaw found in some virulent breast cancers
11. Insects that produce males from unfertilized eggs reveal a surprising cellular feat
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Turning cellular sentinel into cancer killer

(Date:11/4/2014)... Nov. 5, 2014 – University of Utah engineers developed ... help jet fuel produce electricity without needing to ignite ... to power portable electronics, off-grid power and sensors. , ... in the American Chemical Society journal ACS Catalysis ... a chemical reaction between a fuel and an oxygen-rich ...
(Date:11/4/2014)... 4, 2014   ...   Fuel3D , a developer of 3D ... round totaling $6.4 million (£4 million). This funding builds on ... this year and paves the way for the commercial launch ... The funding round was led by Chimera Partners and will ...
(Date:11/3/2014)... 3, 2014  NeuroSigma ® , Inc. (NeuroSigma), ... company focused on commercialization of its non-invasive ... treatment of neurological and neuropsychiatric disorders, announced today ... issued a Notice of Allowance for Mexican Patent ... by NeuroSigma and the Regents of the University ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... December 10, 2013, Shenzhen, China - Chinese researchers ... Medicine, BGI and other institutes identified the recurrent ... Yang 1) are related with insulinoma oncogenesis, implicating ... of functional pancreatic neuroendocrine tumors (PNETs). The latest ...
... has one of the fastest growing human populations in the ... density isn,t yet that high, the number of conflicts between ... on land areas grows. Angela Mwakatobe, who recently defended ... (NTNU) in Trondheim, has studied villages at various distances from ...
... a study led by McGill researcher Sarah Kimmins suggests that ... role in the health of their offspring. It also raises ... of food insecurity. The research focused on vitamin B9, ... green leafy vegetables, cereals, fruit and meats. It is well ...
Cached Biology News:Scientists identified T372R mutation as potential target for diagnosis and treatment of insulinoma 2Serengeti's animals under pressure 2Serengeti's animals under pressure 3You are what your father eats 2
(Date:11/21/2014)... 2014 The science of light and ... with more than 200 primary students in a traveling ... University of Otago Physics Department and funded by an ... members of the university’s OSA/SPIE Student Chapter visited six ... giving children from small, rural schools hands-on lessons in ...
(Date:11/21/2014)... 20, 2014 The November 2014 issue ... an open access journal featuring the following articles:, ... to preserve photoresponsiveness in the retina , ... situ hybridization using chromogenic substrates in zebrafish , ... and protein electrophoresis , Nuclear LC3-positive puncta ...
(Date:11/21/2014)... , Nov. 20, 2014 Polaris Group ... dosed in its Phase 1 trial of ADI-PEG ... the treatment of malignant pleural mesothelioma (MPM) and ... conducting clinical trials on ADI-PEG 20, both as ... the treatment of several other indications, including breast ...
(Date:11/18/2014)... Sarasota, FL (PRWEB) November 17, 2014 ... novel point-of-care diagnostic tests – today announces its ... Control and Prevention’s (CDC) Get Smart About Antibiotics ... Antibiotics Week is a national campaign designed to ... local health departments, and non-profit and for-profit partners ...
Breaking Biology Technology:Optics and photonics outreach programs share science, spark fascination with light 2Optics and photonics outreach programs share science, spark fascination with light 3BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 2RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 3
... CAMBRIDGE, England, June 25 ... service discovery services company at the,forefront of drug discovery ... Ahmedabad, India offering physio-chemical and CYP450 assays. , ... Biology Affiliate Partnership with,Hypoxium Ltd. UK. Hypoxium has specialist ...
... announced the winners of the NWO/Spinoza Prize for 2009. Two ... authors, Marten Scheffer and Albert van den Berg. The prize, ... Dutch award in science and is given for outstanding, pioneering ... EUR 1.5 million, but this year, each of the three ...
... June 24 KBI Biopharma, Inc. (KBI) announced today ... line generation with Crucell,s PER.C6(R) human cell line platform, ... on May 6, 2009. Under that agreement, KBI joins ... generation partner for licensees of the PER.C6(R) cell lines. ...
Cached Biology Technology:O2h and Hypoxium Announce an Agreement to Offer Hypoxium's Specialised In Vitro, Cell-Based Oncology Assays via O2h's Biology Affiliate Program 2KBI Biopharma Starts Cell Line Generation Process under Vendor Network Agreement for PER.C6(R) 2
Goat Anti-Horse IgG(T) Antibody, Unconjugated...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Mouse polyclonal antibody to MCFD2 - multiple coagulation factor deficiency 2...
Rabbit polyclonal to ErbB 2 (phospho Y1248) ( Abpromise for all tested applications). entrezGeneID: 2064 SwissProtID: P04626...
Biology Products: